Literature DB >> 947566

Editorial: Why aspirin?

P W Majerus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 947566     DOI： 10.1161/01.cir.54.3.357

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  Vascular occlusion of the retina--an experimental model. II. Platelet aggregates.

Authors:  H Schroer; G Scheurer; W Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  New perspectives on aspirin.

Authors:  G R Fryers
Journal:  Proc R Soc Med       Date:  1977

Review 3.  The role of eicosanoids in paediatrics.

Authors:  H W Seyberth; P G Kühl
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

4.  Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.

Authors:  M Minkes; N Stanford; M M Chi; G J Roth; A Raz; P Needleman; P W Majerus
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

5.  Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human platelets and sheep seminal vesicles.

Authors:  P W Majerus; N Stanford
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

6.  Inhibition of platelet prostaglandin synthetase by oral aspirin.

Authors:  J W Burch; N Stanford; P W Majerus
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.